Complexities of diagnosis and management of COVID-19 in autoimmune diseases: Potential benefits and detriments of immunosuppression

Table 1 Guidance, recommendations, and statements for management of patients with autoimmune diseases

Disease spectrum	AAD[22]	ACR[23]	AFEF[24]	BCR and NICE[25,26]	BSG[27]	Ceribelli et al[28]	EASL-ESCMID[29]	ECCO[30,31]	EULAR[32]	IPC[33]	Lleo et al[34]	MSIF[35]	Sarzi-Puttini et al[36]	SGEI, ISG and INASL[37]	SIN[38]	Torres et al[39]
RD		X		X		X			X				X
ADD	X									X						X
AIH		X					X				X			X
IBD					X			X					X	X
MS												X			X

AIH: Autoimmune hepatitis; ADD: Autoimmune dermatological disease; IBD: Inflammatory bowel disease; MS: Multiple sclerosis; RD: Rheumatic disease; AAD: American Academy of Dermatology; ACR: American college of rheumatology; AFEF: French Association for the Study of the Liver; BCR: British Society for Rheumatology; NICE: National Institute for Health and Care Excellence; BSG: British Society of Gastroenterology; EASL: European Association for the Study of the Liver; ESCMID: European Society of Clinical Microbiology and Infectious Diseases; ECCO: European Crohn's and Colitis Organization; EULAR: European League Against Rheumatism; IPC: International Psoriasis Council; MSIF: Multiple Sclerosis International Federation; SGEI: Society of Gastrointestinal Endoscopy of India; ISG: India Society of Gastroenterology; INASL: Indian National Association for the Study of the Liver; SIN: Italian Society of Neurology.